Ergoteles LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$74,082
-91.1%
114,131
-76.5%
0.00%
-89.7%
Q3 2022$835,000
-28.1%
485,434
-48.2%
0.03%
-17.1%
Q2 2022$1,162,000
+198.7%
936,900
+337.8%
0.04%
+150.0%
Q3 2021$389,000
+221.5%
214,000
+367.2%
0.01%
+366.7%
Q2 2021$121,000
+181.4%
45,800
+166.3%
0.00%
-50.0%
Q3 2020$43,00017,2000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders